Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?

To: Harry Stein who wrote (285)	7/9/1998 10:42:00 AM
From: Garry K.	Respond to of 572

I recently received a copy of "Lifeline", Xillix's quarterly newsletter. In it there was an update on LIFE-GI.... "In May 1998, Xillix met with some of the world's leading physicians specializing in the gastointestinal tract, which includes the esophagus, stomach and colon, at the annual Digestive Disease Week conference in New Orleans. This Focus Group meeting kicked off the clinical testing of the Xillix LIFE-GI Fluorescence Endoscopy System (TM) in Canada, Japan and Europe. At the Focus Group meeting, physicians shared their early results using the Xillix LIFE-GI system and finalized the protocol. The Focus Group is made up of leaders in the field hand picked by Olympus Optical Co. Ltd. of Tokyo, Xillix's worldwide distribution partner, and by Xillix." It appears Xillix is on schedule with the development of LIFE-GI, and have some influential professionals testing the technology. Garry